Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEC14-like protein 2 (SEC14L2) is a cytosolic carrier protein and member of the lipid-binding SEC14 domain family. It binds hydrophobic molecules, notably alpha-tocopherol (vitamin E), with high affinity, and is involved in the cellular uptake and intracellular transport of vitamin E and its derivatives[1][3][6]. SEC14L2 stimulates squalene monooxygenase, a key enzyme in the cholesterol biosynthetic pathway, and binds squalene, implicating it in the regulation of cholesterol metabolism[3][5][6]. This protein modulates signaling pathways by enhancing vitamin E-mediated protection against lipid peroxidation, regulating the availability of phosphoinositides, and integrating signals through phospholipase C, PIP2 turnover, and intracellular calcium release[1][7]. It acts as a host factor that enhances hepatitis C virus (HCV) replication by protecting cells from oxidative damage[1]. SEC14L2 is linked to human disease susceptibility, including neurodegenerative disorders, cancer, and inherited vitamin E deficiency[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SEC14-like protein 2 (SEC14L2).